Farokhnia, M
Dr Benjamin Scirica, lead author of one of the studies and a professor of cardiovascular medicine at Harvard Medical School, said the findings "reinforce that overweight and obesity increases the risk of death due to many etiologies"
Some patients report that their bupropion seems less effective after losing significant weight on tirzepatide
Wegovy is another brand-name medication of semaglutide that is specifically approved for weight loss in obese (BMI 30kg/m or greater) and overweight patients (BMI 27/m or greater) with at least one obesity related health condition (such as heart disease, hyperlipidemia, hypertension, and hypercholesterolemia) and managing metabolic dysfunction-associated steatohepatitis (MASH) in patients with moderate to advanced liver fibrosis
Using expired Semaglutide may reduce its effectiveness and could pose health risks
Underlying Conditions : Persistent fatigue may also be due to coexisting conditions unrelated to semaglutide, such as anemia, thyroid dysfunction, vitamin B12 deficiency, or vitamin D deficiency
